Navigating Primary Immune Thrombocytopenia During Pregnancy With Management Strategies and Considerations: A...

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Immunology

Background:

• Primary immune thrombocytopenia (ITP) is an autoimmune disorder causing low platelet counts.
• ITP in pregnancy poses risks to both mother and fetus, including hemorrhage and neonatal thrombocytopenia.
• Individualized care is essential for managing ITP during pregnancy.

Purpose of the Study:

• To provide a comprehensive review of ITP pathophysiology, diagnosis, and management in pregnant women.
• To emphasize multidisciplinary care and individualized treatment strategies.
• To enhance clinical decision-making for improved maternal and fetal outcomes in ITP pregnancies.

Main Methods:

• Literature review of current practices and emerging therapies for ITP in pregnancy.
• Analysis of diagnostic criteria and management guidelines.
• Synthesis of information on first-line and second-line treatment options.

Main Results:

• ITP incidence in pregnancy is significant, with potential for serious complications.
• Corticosteroids and IVIG are common first-line treatments.
• Immunosuppressive agents and TPO-RAs are considered second-line options.

Conclusions:

• Effective management of ITP in pregnancy necessitates multidisciplinary collaboration.
• Treatment plans require careful monitoring and adjustment based on thrombocytopenia severity and gestational stage.
• This review aims to improve outcomes through detailed analysis of current and emerging ITP therapies.